


Pathology Nucleus
Medical and Diagnostic Laboratories • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 6215 |
| Keywords | Clinical Trials, Pathology, Diagnostics, Artificial Intelligence, Digital Pathology, Remote Reporting |
| Founded | 2024 |
| Employees | 1-10 |
Key Contact at Pathology Nucleus
Maximiliano Ramia
Director
About Pathology Nucleus
Pathology Nucleus is a consultant-led pathology services company providing high-quality diagnostics, dataset annotation, and research support. We work with global pharmaceutical companies, CROs, and NHS providers to accelerate diagnostics, develop and validate AI tools, and deliver reliable pathology expertise at scale. Our services include: • Preclinical Pathology: toxicology slide review, tumour models, biomarker scoring. • Clinical Trials: central biopsy review, reproducible scoring frameworks (PD-L1, HER2), independent QC of vendor/AI outputs. • Dataset Annotation: tumour/stroma segmentation, immune infiltrates, hybrid scientist + consultant workflows. • Consultancy: study reports, FDA/EMA alignment, publication support. Why PN? ✔ Consultant-led — GMC & ABPath-certified pathologists. ✔ Scalable — network of scientists and consultants. ✔ Compliant — GDPR, HIPAA, SOPs, DPIAs in place. ✔ Fast & global — flexible remote delivery. ✔ Cost-efficient — competitive pricing with batch and fixed-fee options. 🔹 Services: • Diagnostic Reporting • AI & Dataset Annotation • Clinical Trial Pathology • Pharma & CRO Support
Pathology Nucleus revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical and Diagnostic Laboratories industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Pathology Nucleus has never raised funding before.
Frequently asked questions
4.8
40,000 users



